Net margin is calculated as Net Income divided by its Revenue. Elekta AB's Net Income for the
three
months ended in Apr. 2026 was MXN-1,637 Mil. Elekta AB's Revenue for the
three
months ended in Apr. 2026 was MXN8,999 Mil. Therefore, Elekta AB's net margin for the quarter that ended in Apr. 2026 was -18.19%.
The historical rank and industry rank for Elekta AB's Net Margin % or its related term are showing as below:
MEX:EKTAB N'
s Net Margin % Range Over the Past 10 Years
Min: -3.11 Med: 7.31 Max: 11.65
Current: -3.11
MEX:EKTAB N's Net Margin % is ranked worse than 57.65% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs MEX:EKTAB N: -3.11
Elekta AB (MEX:EKTAB N) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Elekta AB Net Margin % Related Terms
Elekta AB Net Margin % Historical Data
* Premium members only.
The historical data trend for Elekta AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:EKTAB N vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Elekta AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elekta AB Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where Elekta AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elekta AB (MEX:EKTAB N) has a Net Margin % of -18.19% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on Elekta AB and its competitors. According to the industry distribution chart, Elekta AB ranks #471 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 57.6%.
Is Elekta AB's Net Margin % too high?
Elekta AB's current Net Margin % is -18.19%. Based on the distribution chart, Elekta AB ranks #471 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Elekta AB has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Elekta AB ranks #471 out of 817 companies for Net Margin %. This places Elekta AB in the lower half of its industry. The industry median Net Margin % is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Elekta AB and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elekta AB's current Net Margin % is -18.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Elekta AB (MEX:EKTAB N) has a current Net Margin % of -18.19%. The stock's GF Value™ is MXN158.57, compared to a current price of MXN126.63 — trading 20.1% below its estimated fair value. The current Net Margin % is -18.19%. Elekta AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Elekta AB (MEX:EKTAB N), the current Net Margin % is -18.19% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elekta AB (MEX:EKTAB N) Overvalued in 2026?
Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued.
The current stock price of MXN126.63 is trading 20.1% below its estimated GF Value™ of MXN158.57.
Key valuation signals for MEX:EKTAB N:
Net Margin %: -18.19%
GF Value™: MXN158.57 vs. price of MXN126.63 (20.1% below fair value)
No single metric tells the full story. See the MEX:EKTAB N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
79GF Score
Get the complete analysis for MEX:EKTAB N
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EKTAB N has been successfully added to your 
